IE45054B1 - Pharmaceutical products for veterinary use - Google Patents
Pharmaceutical products for veterinary useInfo
- Publication number
- IE45054B1 IE45054B1 IE933/77A IE93377A IE45054B1 IE 45054 B1 IE45054 B1 IE 45054B1 IE 933/77 A IE933/77 A IE 933/77A IE 93377 A IE93377 A IE 93377A IE 45054 B1 IE45054 B1 IE 45054B1
- Authority
- IE
- Ireland
- Prior art keywords
- composition
- animal
- breed
- substance
- product
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
Abstract
The process according to the invention consists of adding specific odoriferous substances and flavouring substances to veterinary medical preparations which are designed for oral administration. The purpose of the specific aromatisation is, on the one hand, to mask the pharmaceutical active compounds and, on the other hand, to stimulate appetence. In this way, the consumption of the preparations by the animal to be treated is significantly facilitated.
Description
Thio invention relates to compositions and to methods of manufacture of compositions of pharmaceutical products that have application in veterinary practice, to the products of the said methods of manufacture and to ways of administering the compositions. The purpose of tho invention ia‘to enable the pharmaceutical products to be taken core easily by animals and thus to improve the uptake of tho products by animals being treated by the oral route of administration.
According to the present invention there is provided a composition of a pharmaceutical product for veterinary use, in which the product has added thorofeo or chemically conbinad therein a natural or an artificial odorous or flavouring substance specific to a species and/or to a breed of animal, for oral administration to that species or breed of animal.
The composition may be made by a method including adding or combining a flavouring or odorous substanco to or with a pharmaceutical product, which substance io specific to the species and/or breed of animal.
Tho composition is manufactured in embodiments of the invention by (physically) adding to or chemically combining with a pharmaceutical product without losing odour or flavour a naturally occurring or artificially produced odorous or flavouring substance. In the compositions of those embodiments the odorous or flavouring substance is specifically associated with a particular species or breed of animal? such compositions are for treating the particular
-2breed or species of animal by oral administration.
One or more than one odorous or flavouring substance can be added to or combined with the pharmaceutical product during manufacture of the composition.
In order to enable the invention to be better understood a particular embodiment of the invention will now be described, by way of example.
In the composition of a pharmaceutical product which is intended to be taken by young pigs, a quantity of an artificial flavouring substance having the flavour of sow’s milk is added to the product in an amount sufficient to flavour the composition and make it more palatable to young pigs. The amount of the substance to be added to the product will be apparent to those skilled in the art of manufacturing compositions of pharmaceutical and feed products containing flavouring substances which are not specifically associated with any particular recipient.
A composition containing the pharmaceutical product and the odorous or flavouring substance can be administered to an animal in one or more states of aggregation with other substances. Furthermore, it can be administered alone, as a mixture with atmospheric air, with the drinking water or with the food of the animal, or with a combination thereof.
It is possible to cover the composition with a coating which may or may not include nourishment or feed components. Furthermore the composition can include a carrier substance for the pharmaceutical element of the
composition. It is possible for the carrier substance to include nourishment or feed components. It will be understood that the odorous or flavouring substance can also be included in the carrier substance.
The amount in the composition of the odorous or flavouring substance employed can be solocted according to tha age and/or the alimentary physiological capaci ty of absorption of the animals.
In one.application of the invention, the amount of the pharmaceutical product In the composition is oo low that the composition haa merely a prophylactic offect on ths animal.
In another application, the content of the pharma·»· eeutical element of the composition merely gives a nutritive character.'
It will bs appreciated that although tha invention has been described, by way of example, with reference to particular embodiments, variations and modifications can be made within the scope of the invention claimed.
Claims (10)
1. A composition of a pharmaceutical product for veterinary use in which the product has added thereto or chemically combined therein a natural or an artificial 5 odorous or flavouring substance specific to a species and/or to a breed of animal, for oral administration to that specie or breed of animal.
2. A method for oral administration to a said species and/or breed of said animal of the composition of claim 1, 10 in which the composition is administered in any state of aggregation with other materials, alone, or as admixture to atmospheric air, to drinking water or to the food of the animal or in a combination thereof.
3. The composition as claimed in claim 1, in which 15 the composition is provided with a coating.
4. The Composition as claimed in claim 1 or 2, in which the composition includes a carrier substance for the pharmaceutical product.
5. The composition as claimed in claim 3, in which 30 the coating includes nourishment or feed components.
6. The composition as claimed in claim 4, in which the carrier substance includes nourishment or feed components 57. A composition as claimed in claim 1 or any ono of olaims 3 to 6, in which the amount of said odorous or flavouring substances is selected according to the age and/or the alimentary physiological capacity of absorption of tha 5 specific breed or species of animal for whose use tho product is intended.
7. 8. A composition ao claimed in claim 1 or any one of claims 3 to 7, in which the content of the pharmaceutical ! product in the composition is so low that said composition 10 has merely a prophylactic character; or in which the proportion of the pharmaceutical product merely gives a nutritive character.
8. 9» A method of making the composition defined in claim 1 or in any one of claims 3 to 8, comprising adding or 15 combining a flavouring or odorous substance to or with a pharmaceutical product, said substance being specific to the species and/or breed of animal.
9.
10. A composition made in accordance with the method described herein with reference to the particular embodiment 20 of the invention.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH586276A CH630808A5 (en) | 1976-05-08 | 1976-05-08 | Process for aromatising pharmaceutical preparations for veterinary medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE45054L IE45054L (en) | 1977-11-08 |
| IE45054B1 true IE45054B1 (en) | 1982-06-16 |
Family
ID=4300540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE933/77A IE45054B1 (en) | 1976-05-08 | 1977-05-06 | Pharmaceutical products for veterinary use |
Country Status (11)
| Country | Link |
|---|---|
| AT (1) | AT355859B (en) |
| AU (1) | AU2609277A (en) |
| CA (1) | CA1102240A (en) |
| CH (1) | CH630808A5 (en) |
| DE (1) | DE2716269A1 (en) |
| DK (1) | DK192277A (en) |
| FR (1) | FR2350105A1 (en) |
| GB (1) | GB1577765A (en) |
| IE (1) | IE45054B1 (en) |
| NL (1) | NL7704768A (en) |
| ZA (1) | ZA772514B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8980894B2 (en) | 2004-03-25 | 2015-03-17 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure |
| EP1579862A1 (en) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
| EP1920785A1 (en) | 2006-11-07 | 2008-05-14 | Boehringer Ingelheim Vetmedica Gmbh | Liquid preparation comprising a complex of pimobendan and cyclodextrin |
| FR2934156B1 (en) * | 2008-07-23 | 2010-09-24 | Virbac | ORAL ADMINISTRATION MEDICAMENT IN SOLID FORM |
| WO2014033230A1 (en) | 2012-08-31 | 2014-03-06 | Friulchem Spa | Compositions for oral administration to animals, production methods thereof and uses of same |
| DK2755498T3 (en) | 2011-09-15 | 2018-05-22 | Friulchem Spa | COMPOSITION FOR ORAL ADMINISTRATION FOR ANIMALS AND PROCEDURE FOR OBTAINING |
| EP2825159B1 (en) | 2012-03-15 | 2022-06-22 | Boehringer Ingelheim Vetmedica GmbH | Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof |
| PL3021832T3 (en) | 2013-07-19 | 2021-08-23 | Boehringer Ingelheim Vetmedica Gmbh | Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition |
| BR112016011111B1 (en) | 2013-12-04 | 2022-11-16 | Boehringer Ingelheim Vetmedica Gmbh | IMPROVED PHARMACEUTICAL COMPOSITIONS OF PIMOBENDAN |
| US10537570B2 (en) | 2016-04-06 | 2020-01-21 | Boehringer Ingelheim Vetmedica Gmbh | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease |
-
1976
- 1976-05-08 CH CH586276A patent/CH630808A5/en not_active IP Right Cessation
-
1977
- 1977-04-13 DE DE19772716269 patent/DE2716269A1/en not_active Withdrawn
- 1977-04-21 CA CA276,697A patent/CA1102240A/en not_active Expired
- 1977-04-27 ZA ZA00772514A patent/ZA772514B/en unknown
- 1977-05-02 NL NL7704768A patent/NL7704768A/en not_active Application Discontinuation
- 1977-05-03 GB GB18506/77A patent/GB1577765A/en not_active Expired
- 1977-05-03 DK DK192277A patent/DK192277A/en unknown
- 1977-05-04 AT AT316177A patent/AT355859B/en not_active IP Right Cessation
- 1977-05-06 FR FR7713960A patent/FR2350105A1/en active Granted
- 1977-05-06 IE IE933/77A patent/IE45054B1/en unknown
- 1977-06-14 AU AU26092/77A patent/AU2609277A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DK192277A (en) | 1977-11-09 |
| CH630808A5 (en) | 1982-07-15 |
| DE2716269A1 (en) | 1977-11-17 |
| AU2609277A (en) | 1978-12-21 |
| IE45054L (en) | 1977-11-08 |
| ATA316177A (en) | 1979-08-15 |
| CA1102240A (en) | 1981-06-02 |
| AT355859B (en) | 1980-03-25 |
| NL7704768A (en) | 1977-11-10 |
| GB1577765A (en) | 1980-10-29 |
| FR2350105B3 (en) | 1980-03-07 |
| ZA772514B (en) | 1978-04-26 |
| FR2350105A1 (en) | 1977-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Miller et al. | Experimental zinc deficiency and recovery of calves | |
| JPS6212A (en) | Bait product containing methylsulfonylmethane and use | |
| TR28853A (en) | A preparation for controlled delivery of active ingredients which are suitable for therapeutic or rearing animals to improve development and to evaluate feed. | |
| US5904928A (en) | Antitartar composition and its use in food supplements for animals | |
| KR950011734B1 (en) | Feed and feed additive for livestock poultry and fish for increasing disease, pseudorabies resistance | |
| IE45054B1 (en) | Pharmaceutical products for veterinary use | |
| US4251509A (en) | Dry particulate vaccine for oral administration | |
| Kroneman et al. | Hereditary zinc deficiency in Dutch Friesian cattle | |
| CN109287936A (en) | It is a kind of feeding compound to take off mould dose and its preparation method and application | |
| FR2510875A1 (en) | FEEDING FOOD AND ADDITIVES AND METHOD OF MAKING THE SAME | |
| US4016294A (en) | Animal feeds for herbivorous domestic animals | |
| CN1057753A (en) | Compound bait for angling in fresh water and preparation technology | |
| JPH10146156A (en) | Pellet feed for pig | |
| HU191245B (en) | Process for the production of stbale pharmaceutical preparation against ketosis | |
| Arilov et al. | Sheep productivity when probiotic feed additive “Amilocin” introduced into the diets | |
| Scott et al. | The nature of osteogenesis imperfecta in cats: evidence that the disorder is primarily nutritional, not genetic, and therefore not analogous to the disease in man | |
| JP2005531318A (en) | Vitamin-containing systems to stabilize animal immune responses | |
| RU2202223C2 (en) | Fodder additive for poultry for preparation of egg with increased content of iodine and method of its feeding | |
| JPS58113135A (en) | Poultry growth promoting method | |
| JP3578468B2 (en) | Small livestock pellets or granules | |
| RU2158517C1 (en) | Physiologically active agent for farm animals and poultry, method of preparation thereof, feed additive, and method of feeding animals and poultry | |
| RU2030178C1 (en) | Adaptogenic agent | |
| JP3212364B2 (en) | New royal jelly formulation | |
| JPH037545A (en) | Production of feed additive for domestic animals | |
| KR970005184B1 (en) | Soft capsule containing calcium |